U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433192) titled 'POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.' on Feb. 19.
Brief Summary: In this non-interventional study, the effectiveness and tolerability of Lusefi(R) in adult patients with type 2 diabetes will be evaluated.
Study Start Date: March 30
Study Type: OBSERVATIONAL
Condition:
Type 2 Diabetes Mellitus
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Servier Russia
Published by HT Digital Content Services with permission from Health Daily Digest....